Background: top view of DNA double helix, courtesy of UCSF Computer Graphics Laboratory
Text size:  A  A  A
Research Funding
Training & Careers
Minority Programs
News & Events
News Releases & Research Briefs
Meetings & Reports
NIGMS Research Around the Nation
Features & Honors
Fact Sheets
Publications
NIGMS Media Resources
About NIGMS
Email this link (opens in separate window) E-mail this link

NEWS & EVENTS

Hepatitis C Study May Lead to New Treatments

Hepatitis C Study May Lead to New Treatments

by Alisa Zapp Machalek
April 2, 2002

Every year, hepatitis C kills up to 10,000 Americans and costs $600 million in health care expenses and lost wages.1 Most people who are infected develop chronic liver disease, cirrhosis, or liver cancer. Treatments for the disease usually fail, which is why finding new ways to target the virus is so important.

Dr. Joachim Frank of New York's Wadsworth Center led a research group that showed how the hepatitis C virus takes over a host cell's protein-making machinery, known as the ribosome, and forces it to churn out viral proteins for constructing more virus particles.2 This eventually kills the host cell and allows the spread of the new virus particles to other cells. Using a cryo-electron microscopy technique that he pioneered, Dr. Frank and his group captured the first image of viral genetic material bound to a ribosome and poised to trigger protein synthesis. The image revealed that the end of the virus' genetic material twists into a hook that snags the host's ribosomes. This viral hook forces the ribosomes to change shape dramatically, ensuring that they crank out viral proteins rather than host cell proteins.

By providing a clear view of how hepatitis C commandeers cell machinery in an infected host, the work may point to new molecular targets for drugs to treat the disease. Other viruses--such as those that cause polio, foot-and-mouth disease, and a type of herpes--are thought to use similar infection strategies. A better understanding of how hepatitis C infects cells may also advance efforts to design drugs to treat these viruses. More generally, the work improves our understanding of how proteins are made--a cellular process essential for all life.

REFERENCES

1Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998; 47(No. RR-19): 1-33.

2Spahn CMT, Keift JS, Grassucci RA, Penczek PA, Zhou K, Doudna JA, Frank J. Hepatitis C virus IRES RNA-induced changes in the conformation of the 40S ribosomal subunit. Science 291:1959-62, 2001.

Reporters may call the NIGMS Office of Communications and Public Liaison at (301) 496-7301 to obtain the name of an NIGMS scientist who can comment on this work.

 
 
TOP OF PAGE

 
Research Funding | Training & Careers | Minority Programs
News & Events | About NIGMS | NIGMS Home | NIH Home

Privacy | Accessibility | Disclaimer | Contact Us

Last reviewed: April 2, 2002

Go to the National Institutes of Health Web site 40 Years of Discovery: NIGMS Anniversary Go to the NIGMS Web site home page National Institute of General Medical Sciences NIGMS logo